UNIVERZITETNI KLINICNI CENTER MARIBOR

At UNIVERZITETNI KLINICNI CENTER MARIBOR, clinical trials in neoplasms focus on improving treatment options for difficult-to-treat cancers, especially non-small cell lung cancer, relapsed/refractory multiple myeloma, and endometrial cancer. These studies are designed to compare new therapies with existing standards and to better understand how well they control disease.

• Testing new treatment approaches for advanced lung cancer and other solid tumors
• Evaluating therapies for relapsed/refractory multiple myeloma to improve disease control
• Studying options for advanced endometrial cancer after prior treatment has stopped working

This research reflects a strong interest in finding more effective and better-tolerated cancer treatments for patients with limited options.

The site is active in nervous system diseases, with trials centered on multiple sclerosis, refractory focal onset epilepsy, and Alzheimer’s disease-related cognitive and behavioral symptoms. The main goal is to evaluate whether new therapies can slow progression, reduce relapses or seizures, and improve daily functioning.

• Assessing treatments for relapsing-remitting multiple sclerosis and related forms of the disease
• Studying therapies for refractory focal onset epilepsy to reduce seizure frequency
• Exploring approaches for mild cognitive impairment, mild dementia, and agitation in Alzheimer’s disease

This area combines symptom relief with long-term disease management, especially in conditions where better control can make a meaningful difference in quality of life.

Several trials at the Maribor site address immune system diseases and related inflammatory conditions, including ulcerative colitis, hidradenitis suppurativa, and Sjögren’s syndrome. Researchers are evaluating whether new therapies can reduce symptoms, calm inflammation, and improve patient-reported outcomes.

• Investigating treatments for moderate to severe ulcerative colitis
• Studying therapies for hidradenitis suppurativa to lessen signs and symptoms
• Evaluating options for Sjögren’s syndrome, including systemic and symptom-focused disease control

This research highlights a broad effort to improve care for chronic inflammatory diseases that can affect multiple organs and everyday comfort.

Trials in cardiovascular diseases at this hospital focus on urgent and high-risk settings such as acute myocardial infarction complicated by cardiogenic shock. The aim is to test treatment strategies that may improve survival, protect organ function, and support recovery in critically ill patients.

• Studying care strategies for cardiogenic shock after acute myocardial infarction
• Evaluating whether treatment adjustments can improve short-term outcomes in critical care
• Exploring ways to reduce mortality and serious complications in unstable cardiac patients

This work reflects an emphasis on practical improvements in emergency and intensive care medicine.

The site also contributes to studies in hemic and lymphatic diseases and kidney-related immune disorders, particularly IgA nephropathy and immune-mediated proteinuria. These trials are designed to determine whether new treatments can slow disease progression and preserve kidney function.

• Assessing therapies for primary IgA nephropathy and reducing protein loss in the urine
• Studying approaches to slow decline in kidney function
• Evaluating longer-term safety and effectiveness of emerging immune-targeted treatments

This research supports better management of chronic kidney disease linked to immune system activity.

Clinical research at UNIVERZITETNI KLINICNI CENTER MARIBOR includes trials for less common disorders such as chronic inflammatory demyelinating polyneuropathy and other immune-driven neurologic diseases. The purpose is to compare therapies that may improve strength, function, and long-term disease control.

• Testing treatment effectiveness in chronic inflammatory demyelinating polyneuropathy
• Evaluating whether new immune-targeted therapies can improve functional ability
• Looking at sustained safety and symptom control in rare neurologic disease

This area shows the site’s involvement in research for conditions where patients often have limited treatment choices and a strong need for better long-term outcomes.

Some studies at the center span broader clinical questions across phenomena and processes, including treatment support, symptom management, and overall patient outcomes in complex illness. These trials often aim to improve how existing care works in real-world hospital settings.

• Evaluating supportive care strategies in seriously ill or medically complex patients
• Studying ways to improve symptom relief and quality of life across different diseases
• Assessing whether new approaches can complement standard hospital care

This reflects a flexible research profile that extends beyond one specialty and supports a wide range of clinical needs.